Abstract
Many human and experimental cancers express abnormal proteins, including the products of mutated oncogenes, tumor suppressor genes, or viral genes, fusion proteins resulting from translocations, or products of normal but silent genes (1). At least some of these abnormal proteins should be recognized as antigens by T lymphocytes and induce an immune response leading to tumor rejection. However, these antigens are tolerated by the immune system, and tumors, instead of being rejected, progress and ultimately kill their host. Among other mechanisms, a defect in the presentation of tumor antigens to the immune system could explain this tolerance.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Boon, T., Cerottini, J.C., Van Den Eynde, B., Van Der Bruggen, R. and Van PeI, A., Tumor rejection antigens recognized by T lymphocytes. A.nu. Rev. Immunol., 12, 337–365 (1994).
Caignard, A., Martin, M.S., Michel, M.F. and Martin, F., Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host. Int. J. Cancer, 36, 273–279 (1985).
Caignard, A., Pelletier, H. and Martin, F., Specificity of the immune response leading to protection or enhancement by regressive and progressive variants of a rat colon carcinoma. Int. J. Cancer, 42, 883–886 (1988).
Chaux, P., Hammann, A., Martin, F. and Martin, M., Surface phenotype and functions of tumor-infiltrating dendritic cells: CD8 expression by a cell subpopulation. Eur. J. Immunol., 23, 2517–2525 (1993).
Caux C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, 1. and Banchereau, J., Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med., 180, 1263–1272 (1994).
Schwartz, R.H., Costimulation of T lymphocytes: the role of CD28, CTLA4, and B7/BBI in interleukin-2 production and immunotherapy. Cell, 71, 1065–1068 (1992).
Gimmi, C.D., Freeman, G.J., Gribben, J.G., Gray, G. and Nadler, L.M., Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl. Acad. Sci. (USA), 90, 6586–6590 (1993).
Harding, F.A., McArthur, J.G., Gross, J.A., Raulet, D.H. and Allison, J.P., CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature, 356, 607–609 609 (1992).
Chaux, R, Moutet, M., Faivre, J., Martin, F. and Martin, M. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7–1 and B7–2 costimulatory molecules of the T cell activation. Lab. Invest. 74, 975–983 (1996).
Linsley, P.S., Brady, W., Urnes, M., Grosmaire, L.S., Damle, N.K. and Ledbetter, J.A., CTLA4 is a second receptor for the B cell activation antigen B7. J. Exp. Med., 174, 561–569 (1991).
Chaux, R, Martin, M.S. and Martin, F. T-cell costimulation by the CD28 ligand B7 is involved in the immune response leading to rejection of a spontaneously regressive tumor. Int. J. Cancer 66, 244–248 (1996).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chaux, P., Favre, N., Bonnotte, B., Moutet, M., Martin, M., Martin, F. (1997). Tumor-Infiltrating Dendritic Cells are Defective in Their Antigen-Presenting Function and Inducible B7 Expression. In: Ricciardi-Castagnoli, P. (eds) Dendritic Cells in Fundamental and Clinical Immunology. Advances in Experimental Medicine and Biology, vol 417. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9966-8_86
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9966-8_86
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9968-2
Online ISBN: 978-1-4757-9966-8
eBook Packages: Springer Book Archive